Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Product/R&D News
 
Shionogi’s Thrombopoietin Receptor Agonist Lusutrombopag Granted... 10/14/2019
Harbour BioMed Completes Phase 2 Chinese Study of HBM9036 for Dry... 10/14/2019
CBMG Builds R&D Center in MD as Its ReJoin Stem Cell Therapy Acce... (free) 10/3/2019
NMPA Approves IND for Fully-human BCMA CAR-T 10/3/2019
Mitsubishi Tanabe Files for Tenelia (Teneligliptin) Approval in C... 9/24/2019
Xynomic Pharma Wins FDA Fast-Track Designation of Abexinostat for... 9/23/2019
Clinical Investigation Begins for China-developed Novel Chronic P... 9/20/2019
MicuRx Reports Positive Top-line Results of a China Phase 3 Trial... 9/20/2019
ASLAN Pharma Presents China Phase 2 Data for Varlitinib in Second... 9/19/2019
CASI Announces NMPA Acceptance of Its Clinical Trial Application ... 9/17/2019
Hansoh Atomwise Launch Strategic AI Drug Discovery Collaboration ... 9/11/2019
Athenex Announces Initiation of Phase I Trial in China of KX2-361... 9/11/2019
Xynomic Pharma Reports Encouraging Data on Lead Cancer Drug 8/30/2019
AZ's Breztri COPD Candidate Aerosphere (PT010) Maybe Approved in ... 8/29/2019
USFDA Grants Priority Review to BeiGene's Zanubrutinib in Patient... 8/21/2019
CDE Accepts Clinical Trial Application of Gilead's NASH drug Selo... 8/21/2019
Sanofi Gains Chinese IND Approval for RNAi Therapy Fitusiran Inje... 8/19/2019
Ascletis Received IND Approval and Management Outlook of 2019 and... 8/7/2019
3SBio's Enbrel Biosimilar To Be Available as Pre-filled Syringe i... 8/5/2019
I-Mab and TRACON Initiate Phase 1 Trial of CD73 Antibody TJD5 8/2/2019
China Approved 139 New Drugs Supported by the National S&T Major ... 8/1/2019
Xynomic Received China Approval to Start 2 Pivotal Lymphoma Clini... 7/30/2019
Chi-Med Set to Add Two New Anticancer Registration Filings in Chi... 7/30/2019
CANbridge Pharma Submits NDA Hunter Syndrome Drug in China 7/29/2019
Pfizer Gets Accelerated Review and Foreign Clinical Data Acceptan... 7/29/2019
Ascentage to Initiate Phase Ib Study of HQP1351 for Chronic Myelo... 7/22/2019
China Begins Phase II Trial of Long-lasting HIV Vaccine 7/19/2019
Takeda Files NDA for Entyvio (Vedolizumab) in China 7/12/2019
Novartis Files NDA for Second Indication of Dabrafenib/Trametinib... 7/12/2019
Priority Review Granted to BeiGene’s Supplemental NDA in China f... 7/9/2019
Page:1/4    Total number of articles:99  :[1][2][3][4]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links